These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 7140524)

  • 1. When to treat symptomless essential hypertension.
    Drug Ther Bull; 1982 Jul; 20(14):53-4. PubMed ID: 7140524
    [No Abstract]   [Full Text] [Related]  

  • 2. How to treat benign essential hypertension.
    Tobian L
    GP; 1968 May; 37(5):125-32. PubMed ID: 5648395
    [No Abstract]   [Full Text] [Related]  

  • 3. Nicardipine or propranolol combined with hydrochlorothiazide in patients with essential hypertension.
    Arriaga-Gracia J; Sánchez-Garcia JL; González-García CA
    Proc West Pharmacol Soc; 1993; 36():39-43. PubMed ID: 8378396
    [No Abstract]   [Full Text] [Related]  

  • 4. The effects of amlodipine on cerebral circulatory values in patients with essential hypertension.
    Alizade IG; Karayeva NT
    Anadolu Kardiyol Derg; 2001 Mar; 1(1):14-6. PubMed ID: 12122965
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety and efficacy of moxonidine in mild to moderate hypertension.
    Jain S; Malhotra P; Kumari S; Varma S
    J Assoc Physicians India; 2001 Aug; 49():829-30. PubMed ID: 11837474
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of endopeptidase EC 3.4.24.11 by candoxatril lowered blood pressure and increased urinary but not plasma atrial natriuretic peptide in essential hypertension.
    Tunny TJ; Ziesak MD; Armstrong R; Klemm SA; Stowasser M; Finn WL; Gordon RD
    J Hypertens Suppl; 1993 Dec; 11(5):S222-3. PubMed ID: 8158355
    [No Abstract]   [Full Text] [Related]  

  • 7. Hypertension in the elderly: 12 tips on when and how to treat it.
    Sheehy TW
    Med Times; 1980 Jun; 108(6):31-7. PubMed ID: 7382780
    [No Abstract]   [Full Text] [Related]  

  • 8. Shall we treat isolated systolic hypertension in 1994?
    Bulpitt CJ
    J Hum Hypertens; 1994 Oct; 8(10):785-8. PubMed ID: 7837217
    [No Abstract]   [Full Text] [Related]  

  • 9. Role of ketanserin in the treatment of the essential arterial hypertension associated with ischemic heart disease.
    Podoleanu D; Cotoi S
    Rom J Intern Med; 1996; 34(1-2):49-54. PubMed ID: 8908630
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of changes in blood pressure and left ventricular mass induced by antihypertensive treatment on ventricular arrhythmias in essential hypertension.
    Muiesan ML; Zulli R; Rizzoni D; Calebich S; Malerba M; Porteri E; Agabiti-Rosei E
    J Hypertens Suppl; 1993 Dec; 11(5):S104-5. PubMed ID: 8158296
    [No Abstract]   [Full Text] [Related]  

  • 11. [Metoprolol in the treatment of essential hypertension (author's transl)].
    Salgueiro Rodríguez M; Pérez Pombo S; Beiras García E
    Med Clin (Barc); 1981 Feb; 76(3):121-4. PubMed ID: 7206875
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Prospects of use of the combined preparation logimax in patients with essential hypertension].
    Ol'binskaia LI; Khapaev BA; Zheleznykh EA
    Ter Arkh; 2002; 74(1):61-3. PubMed ID: 11878064
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The optimization of Capoten treatment by taking into account its chronosensitivity in hypertension patients].
    Zaslavskaia RM; Akhmetov KZh; Hulberg F; Teiblum MM
    Ter Arkh; 1994; 66(8):7-9. PubMed ID: 7985162
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic value of 24-hour ambulatory blood pressure measurement for the onset of atrial fibrillation in treated patients with essential hypertension.
    Ciaroni S; Bloch A; Lemaire MC; Fournet D; Bettoni M
    Am J Cardiol; 2004 Dec; 94(12):1566-9. PubMed ID: 15589020
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prehypertension. To treat, or not to treat: that is the question.
    Pitt B
    Am J Hypertens; 2007 May; 20(5):492. PubMed ID: 17485008
    [No Abstract]   [Full Text] [Related]  

  • 16. [The pharmacological effect of betapressin in hypertension].
    Zaslavskaia RM; Akhmetov KZh; Gol'denberg VA; Lilitsa GV
    Eksp Klin Farmakol; 1996; 59(6):23-5. PubMed ID: 9181866
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Beneficial effect of T-type calcium channel blockers on endothelial function in patients with essential hypertension.
    Oshima T; Ozono R; Yano Y; Higashi Y; Teragawa H; Miho N; Ishida T; Ishida M; Yoshizumi M; Kambe M
    Hypertens Res; 2005 Nov; 28(11):889-94. PubMed ID: 16555577
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of amlodipine and fosinopril on heart rate variability and left ventricular mass in mild-to-moderate essential hypertension.
    Bilge AK; Atilgan D; Tükek T; Ozcan M; Ozben B; Koylan N; Meriç M
    Int J Clin Pract; 2005 Mar; 59(3):306-10. PubMed ID: 15857327
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enalapril and enalapril-hydrochlorothiazide in the treatment of essential hypertension. The Enalapril-Hydrochlorothiazide in Essential Hypertension Canadian Working Group.
    Clin Ther; 1993; 15(2):364-73. PubMed ID: 8519044
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Dioodobufenine in the treatment of essential arterial hypertension].
    Paladini G; Sgoifo E
    Minerva Cardioangiol; 1980 May; 28(5):303-8. PubMed ID: 7207819
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.